These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3991911)

  • 1. Tricyclic response in obsessive compulsive disorder.
    Insel TR; Mueller EA; Gillin JC; Siever LJ; Murphy DL
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(1):25-31. PubMed ID: 3991911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological markers in obsessive-compulsive and affective disorders.
    Insel TR; Mueller EA; Gillin JC; Siever LJ; Murphy DL
    J Psychiatr Res; 1984; 18(4):407-23. PubMed ID: 6512711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline.
    Insel TR; Murphy DL; Cohen RM; Alterman I; Kilts C; Linnoila M
    Arch Gen Psychiatry; 1983 Jun; 40(6):605-12. PubMed ID: 6342562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology.
    Zohar J; Insel TR
    Biol Psychiatry; 1987 Jun; 22(6):667-87. PubMed ID: 3036259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison.
    Leonard HL; Swedo SE; Rapoport JL; Koby EV; Lenane MC; Cheslow DL; Hamburger SD
    Arch Gen Psychiatry; 1989 Dec; 46(12):1088-92. PubMed ID: 2686576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder.
    Gordon CT; State RC; Nelson JE; Hamburger SD; Rapoport JL
    Arch Gen Psychiatry; 1993 Jun; 50(6):441-7. PubMed ID: 8498878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clomipramine in obsessive-compulsive disorder: clinical response and plasma levels.
    Mavissakalian MR; Jones B; Olson S; Perel JM
    J Clin Psychopharmacol; 1990 Aug; 10(4):261-8. PubMed ID: 2286699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tricyclic antidepressants in obsessive-compulsive disorder: antiobsessional or antidepressant agents? II.
    Mavissakalian M; Turner SM; Michelson L; Jacob R
    Am J Psychiatry; 1985 May; 142(5):572-6. PubMed ID: 3885761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychophysiological changes during pharmacological treatment of patients with obsessive compulsive disorder.
    Zahn TP; Insel TR; Murphy DL
    Br J Psychiatry; 1984 Jul; 145():39-44. PubMed ID: 6378303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling).
    Swedo SE; Leonard HL; Rapoport JL; Lenane MC; Goldberger EL; Cheslow DL
    N Engl J Med; 1989 Aug; 321(8):497-501. PubMed ID: 2761586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment.
    Zohar J; Insel TR; Zohar-Kadouch RC; Hill JL; Murphy DL
    Arch Gen Psychiatry; 1988 Feb; 45(2):167-72. PubMed ID: 3276283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder.
    Barr LC; Goodman WK; Anand A; McDougle CJ; Price LH
    Am J Psychiatry; 1997 Sep; 154(9):1293-5. PubMed ID: 9286191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind desipramine substitution during long-term clomipramine treatment in children and adolescents with obsessive-compulsive disorder.
    Leonard HL; Swedo SE; Lenane MC; Rettew DC; Cheslow DL; Hamburger SD; Rapoport JL
    Arch Gen Psychiatry; 1991 Oct; 48(10):922-7. PubMed ID: 1929762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of childhood obsessive compulsive disorder with clomipramine and desmethylimipramine: a double-blind crossover comparison.
    Leonard H; Swedo S; Rapoport JL; Coffey M; Cheslow D
    Psychopharmacol Bull; 1988; 24(1):93-5. PubMed ID: 3290954
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential response of seven subjects with autistic disorder to clomipramine and desipramine.
    Gordon CT; Rapoport JL; Hamburger SD; State RC; Mannheim GB
    Am J Psychiatry; 1992 Mar; 149(3):363-6. PubMed ID: 1536276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy of obsessive-compulsive disorder.
    Jermain DM; Crismon ML
    Pharmacotherapy; 1990; 10(3):175-98. PubMed ID: 2196535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tricyclic antidepressants in obsessive-compulsive disorder. Antiobsessional or antidepressant agents?
    Mavissakalian M; Michelson L
    J Nerv Ment Dis; 1983 May; 171(5):301-6. PubMed ID: 6343556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study.
    Flament MF; Rapoport JL; Berg CJ; Sceery W; Kilts C; Mellström B; Linnoila M
    Arch Gen Psychiatry; 1985 Oct; 42(10):977-83. PubMed ID: 3899048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.
    Piccinelli M; Pini S; Bellantuono C; Wilkinson G
    Br J Psychiatry; 1995 Apr; 166(4):424-43. PubMed ID: 7795913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results.
    Pigott TA; Pato MT; Bernstein SE; Grover GN; Hill JL; Tolliver TJ; Murphy DL
    Arch Gen Psychiatry; 1990 Oct; 47(10):926-32. PubMed ID: 2222131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.